SUCRALFATE MAY BE AN EFFECTIVE TOPICAL AGENT IN PREVENTING ORAL MUCOSITIS.
Cheng, Linda L. 2024. “SUCRALFATE MAY BE AN EFFECTIVE TOPICAL AGENT IN PREVENTING ORAL MUCOSITIS.”. The Journal of Evidence-Based Dental Practice 24 (4): 102037.
Search
Search results
38 results found
Errata.
Known, Not. 2024. “Errata.”. Missouri Medicine 121 (6): 462.
Author Correction: Evaluation of Potential Drug-Drug Interactions in the Intensive Care Unit.
Dagdelen, M S, D Gulen, I Ceylan, and N K Girgin. 2024. “Author Correction: Evaluation of Potential Drug-Drug Interactions in the Intensive Care Unit.”. European Review for Medical and Pharmacological Sciences 28 (20): 4404.
Erratum: CXCL12 chemokine expression suppresses human breast cancer growth and metastasis in vitro and in vivo.
Lv, Zhi-Dong, Bin Kong, Xiang-Ping Liu, Qian Dong, Hai-Tao Niu, Yong-Hua Wang, Fu-Nian Li, and Hai-Bo Wang. 2024. “Erratum: CXCL12 Chemokine Expression Suppresses Human Breast Cancer Growth and Metastasis in Vitro and in Vivo.”. International Journal of Clinical and Experimental Pathology 17 (10): 381-82.
Erratum: Transfusion Practices in Severely Injured Patients at a Level 1 Trauma Center.
Known, Not. 2024. “Erratum: Transfusion Practices in Severely Injured Patients at a Level 1 Trauma Center.”. Journal of Emergencies, Trauma, and Shock 17 (3): 189.
Retraction: Adding magnesium sulfate to bupivacaine in transversus abdominis plane block for laparoscopic cholecystectomy: A single blinded randomized controlled trial.
Known, Not. 2024. “Retraction: Adding Magnesium Sulfate to Bupivacaine in Transversus Abdominis Plane Block for Laparoscopic Cholecystectomy: A Single Blinded Randomized Controlled Trial.”. Saudi Journal of Anaesthesia 18 (4): 624.
Retraction Note: Functional role of SIRT1-induced HMGB1 expression and acetylation in migration, invasion and angiogenesis of ovarian cancer.
Jiang, W, P Jiang, R Yang, and D-F Liu. 2024. “Retraction Note: Functional Role of SIRT1-Induced HMGB1 Expression and Acetylation in Migration, Invasion and Angiogenesis of Ovarian Cancer.”. European Review for Medical and Pharmacological Sciences 28 (23): 4645.
Retraction Note: MiR-5692a promotes the invasion and metastasis of hepatocellular carcinoma via MMP9.
Sun, S-J, N Wang, Z-W Sun, J Chen, and H-W Cui. 2024. “Retraction Note: MiR-5692a Promotes the Invasion and Metastasis of Hepatocellular Carcinoma via MMP9.”. European Review for Medical and Pharmacological Sciences 28 (23): 4644.